Patent · US Active

Kinase inhibitors and their use as pharmaceutical agents

US8309550B2 · kind B2 · utility

7Cited by

0References

9Claims

0Family size

Assignee

Shanghai Genomics, Inc. · CN

Inventors

Ying Luo · Shanghai, CN
Fang Rui Shu · Shanghai, CN
Shudong Wang · Nottingham, GB

Key dates

Filing date	Apr 27, 2011
Grant date	Nov 13, 2012
Priority date	—
Expiry date	Apr 27, 2031

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D471/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein are compounds that are inhibitors of one or more protein kinases. Also described are pharmaceutical compositions and medicaments that include the compounds described herein. Also described herein are methods of using such protein kinase inhibitors, alone and in combination with other compounds, for conditions or diseases mediated or dependent upon protein kinases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.